2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum

C144H123N12O3Pt3-3 — CID 158299713

IUPAC2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum
SMILESCC(C)(C)c1ccc2[n-]c3c(-c4nc5c(-c6cc(-c7ccccc7)c7cccc(O)c7n6)cccc5n4-c4cccc(-c5ccccc5)c4)cc(C(C)(C)C)cc3c2c1.CC(C)(C)c1ccc2[n-]c3c(-c4nc5c(-c6cc(-c7ccccc7)c7cccc(O)c7n6)cccc5n4-c4ccccc4)cc(C(C)(C)C)cc3c2c1.CC(C)(C)c1ccc2[n-]c3c(-c4nc5c(-c6ccc7cccc(O)c7n6)cccc5n4-c4ccccc4)cc(C(C)(C)C)cc3c2c1.[Pt].[Pt].[Pt]
InChIInChI=1S/C54H45N4O.C48H41N4O.C42H37N4O.3Pt/c1-53(2,3)36-26-27-45-42(29-36)43-30-37(54(4,5)6)31-44(49(43)55-45)52-57-50-40(46-32-41(34-18-11-8-12-19-34)39-22-15-25-48(59)51(39)56-46)23-14-24-47(50)58(52)38-21-13-20-35(28-38)33-16-9-7-10-17-33;1-47(2,3)30-23-24-39-36(25-30)37-26-31(48(4,5)6)27-38(43(37)49-39)46-51-44-34(20-13-21-41(44)52(46)32-17-11-8-12-18-32)40-28-35(29-15-9-7-10-16-29)33-19-14-22-42(53)45(33)50-40;1-41(2,3)26-19-21-34-30(22-26)31-23-27(42(4,5)6)24-32(38(31)44-34)40-45-39-29(33-20-18-25-12-10-17-36(47)37(25)43-33)15-11-16-35(39)46(40)28-13-8-7-9-14-28;;;/h7-32H,1-6H3,(H-,55,56,57,59);7-28H,1-6H3,(H-,49,50,51,53);7-24H,1-6H3,(H-,43,44,45,47);;;/q3*-1;;;
InChIKeyHADKEMJOFWTPPK-UHFFFAOYSA-N
MW2654.88 g/mol
LogP36.41
Rot. Bonds12

About 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum

2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum (PubChem CID 158299713) has the molecular formula C144H123N12O3Pt3-3 and a molecular weight of 2654.88 g/mol. Its IUPAC name is 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum.

Molecular Properties

Compound Name2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum
PubChem CID158299713
Molecular FormulaC144H123N12O3Pt3-3
Molecular Weight2654.88 g/mol
Exact Mass2652.88
IUPAC Name2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum
SMILESCC(C)(C)c1ccc2[n-]c3c(-c4nc5c(-c6cc(-c7ccccc7)c7cccc(O)c7n6)cccc5n4-c4cccc(-c5ccccc5)c4)cc(C(C)(C)C)cc3c2c1.CC(C)(C)c1ccc2[n-]c3c(-c4nc5c(-c6cc(-c7ccccc7)c7cccc(O)c7n6)cccc5n4-c4ccccc4)cc(C(C)(C)C)cc3c2c1.CC(C)(C)c1ccc2[n-]c3c(-c4nc5c(-c6ccc7cccc(O)c7n6)cccc5n4-c4ccccc4)cc(C(C)(C)C)cc3c2c1.[Pt].[Pt].[Pt]
InChIInChI=1S/C54H45N4O.C48H41N4O.C42H37N4O.3Pt/c1-53(2,3)36-26-27-45-42(29-36)43-30-37(54(4,5)6)31-44(49(43)55-45)52-57-50-40(46-32-41(34-18-11-8-12-19-34)39-22-15-25-48(59)51(39)56-46)23-14-24-47(50)58(52)38-21-13-20-35(28-38)33-16-9-7-10-17-33;1-47(2,3)30-23-24-39-36(25-30)37-26-31(48(4,5)6)27-38(43(37)49-39)46-51-44-34(20-13-21-41(44)52(46)32-17-11-8-12-18-32)40-28-35(29-15-9-7-10-16-29)33-19-14-22-42(53)45(33)50-40;1-41(2,3)26-19-21-34-30(22-26)31-23-27(42(4,5)6)24-32(38(31)44-34)40-45-39-29(33-20-18-25-12-10-17-36(47)37(25)43-33)15-11-16-35(39)46(40)28-13-8-7-9-14-28;;;/h7-32H,1-6H3,(H-,55,56,57,59);7-28H,1-6H3,(H-,49,50,51,53);7-24H,1-6H3,(H-,43,44,45,47);;;/q3*-1;;;
InChIKeyHADKEMJOFWTPPK-UHFFFAOYSA-N
XLogP36.41
TPSA195.12 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms162
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002654.88
LogP ≤ 536.41
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Analyze 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-N,4-N-bis[2,5-dimethyl-4-(N-(3-methylphenyl)anilino)phenyl]-2,5-dimethyl-1-N-(3-methylphenyl)-1-N-phenylbenzene-1,4-diamine;1-[4,6-bis[2-(trifluoromethyl)benzimidazol-1-yl]-1,3,5-triazin-2-yl]-2-(trifluoromethyl)benzimidazole;2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline;tri(quinolin-8-yloxy)alumane
CID 158788116
CID 159204676
CID 159204676
2,4-ditert-butyl-6-[1-phenyl-4-[6-[3-(N-phenylanilino)benzene-6-id-1-yl]-4-(trifluoromethyl)-2-pyridinyl]benzimidazol-2-yl]phenol;2,4-ditert-butyl-6-[1-phenyl-4-[6-[3-(N-phenylanilino)phenyl]-4-(trifluoromethyl)-2-pyridinyl]benzimidazol-2-yl]phenol;platinum
CID 160792148
2-[4-[3-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-pyridinyl]-5-tert-butylbenzene-2-id-1-yl]-1-(6-tert-butyl-1,1,2,3,3-pentadeuterio-2-phenylinden-5-yl)benzimidazol-2-yl]-5-tert-butylphenol;2-[4-[3-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-pyridinyl]-5-tert-butylbenzene-2-id-1-yl]-1-[2-deuterio-1,1,3,3-tetramethyl-2-phenyl-6-(trideuteriomethyl)inden-5-yl]benzimidazol-2-yl]phenol;5-tert-butyl-2-[4-[3-tert-butyl-5-[4-(2-deuterio-1,1,3,3-tetramethyl-2-phenylinden-5-yl)-2-pyridinyl]benzene-6-id-1-yl]-1-(2-phenylphenyl)benzimidazol-2-yl]phenol;platinum;platinum(2+);5,5,7,7-tetrafluoro-3-(1H-naphthalen-1-id-2-yl)-6-phenyl-1-[2-[6-(7-phenyl-3H-naphthalen-3-id-2-yl)-2-pyridinyl]propan-2-yl]-6H-cyclopenta[c]pyridine
CID 163759081
(1R,28R)-2,29,57-trioxa-12,27,39,54-tetraza-9,55-diazonia-1,28-diboranuidahexadecacyclo[28.24.2.27,10.11,28.03,8.09,28.011,27.013,26.014,19.020,25.034,56.037,55.038,54.040,53.041,46.047,52]nonapentaconta-3,5,7,9,11,13(26),14,16,18,20,22,24,30,32,34(56),35,37(55),38,40(53),41,43,45,47,49,51,58-hexacosaene
CID 139041013
Tris(2-(1-methylbenzimidazol-2-yl)quinolin-8-olate);praseodymium(3+);propan-2-ol;dihydrate
CID 139128385
Tetrakis(acetonitrile);ethanol;bis(europium(3+));hexakis(2-(1-methylbenzimidazol-2-yl)quinolin-8-olate)
CID 139128386
Bis(acetonitrile);tris(2-(1-butyl-6-methylbenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)
CID 139128387
7-[4-[3,5-Bis[4-(6-hydroxy-5-pyrimidin-5-ylindolo[2,3-b]carbazol-7-yl)phenyl]phenyl]phenyl]-5-pyrimidin-5-ylindolo[2,3-b]carbazol-6-ol
CID 132149251
13'-[4-(1-Phenylbenzimidazol-2-yl)phenyl]-4-[4-[phenyl-(4-spiro[1-azapentacyclo[10.7.1.02,7.08,20.014,19]icosa-2,4,6,8(20),9,11,14,16,18-nonaene-13,7'-chromeno[2,3-a]carbazole]-13'-ylphenyl)phosphoryl]phenyl]spiro[1-azapentacyclo[10.7.1.02,7.08,20.014,19]icosa-2(7),3,5,8(20),9,11,14,16,18-nonaene-13,7'-chromeno[2,3-a]carbazole]
CID 134353482
2-[10-(8-Hydroxyquinolin-2-yl)-3-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-9-yl]quinolin-8-ol
CID 136502643
2-[2-Carbazol-9-id-1-yl-1-(3,5-dimethylphenyl)benzimidazol-4-yl]-4-(3,5-dimethylphenyl)quinolin-8-ol;platinum
CID 145741515

Frequently Asked Questions

What is the IUPAC name of 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum?
The IUPAC name of 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum (CID 158299713) is 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum.
What is the SMILES notation for 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum?
The canonical SMILES for 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum is CC(C)(C)c1ccc2[n-]c3c(-c4nc5c(-c6cc(-c7ccccc7)c7cccc(O)c7n6)cccc5n4-c4cccc(-c5ccccc5)c4)cc(C(C)(C)C)cc3c2c1.CC(C)(C)c1ccc2[n-]c3c(-c4nc5c(-c6cc(-c7ccccc7)c7cccc(O)c7n6)cccc5n4-c4ccccc4)cc(C(C)(C)C)cc3c2c1.CC(C)(C)c1ccc2[n-]c3c(-c4nc5c(-c6ccc7cccc(O)c7n6)cccc5n4-c4ccccc4)cc(C(C)(C)C)cc3c2c1.[Pt].[Pt].[Pt].
What is the InChIKey of 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum?
The InChIKey is HADKEMJOFWTPPK-UHFFFAOYSA-N. The full InChI is InChI=1S/C54H45N4O.C48H41N4O.C42H37N4O.3Pt/c1-53(2,3)36-26-27-45-42(29-36)43-30-37(54(4,5)6)31-44(49(43)55-45)52-57-50-40(46-32-41(34-18-11-8-12-19-34)39-22-15-25-48(59)51(39)56-46)23-14-24-47(50)58(52)38-21-13-20-35(28-38)33-16-9-7-10-17-33;1-47(2,3)30-23-24-39-36(25-30)37-26-31(48(4,5)6)27-38(43(37)49-39)46-51-44-34(20-13-21-41(44)52(46)32-17-11-8-12-18-32)40-28-35(29-15-9-7-10-16-29)33-19-14-22-42(53)45(33)50-40;1-41(2,3)26-19-21-34-30(22-26)31-23-27(42(4,5)6)24-32(38(31)44-34)40-45-39-29(33-20-18-25-12-10-17-36(47)37(25)43-33)15-11-16-35(39)46(40)28-13-8-7-9-14-28;;;/h7-32H,1-6H3,(H-,55,56,57,59);7-28H,1-6H3,(H-,49,50,51,53);7-24H,1-6H3,(H-,43,44,45,47);;;/q3*-1;;;.
What are the key properties of 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum?
2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum has a molecular weight of 2654.88 g/mol, XLogP of 36.41, 12 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]-4-phenylquinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-phenylbenzimidazol-4-yl]quinolin-8-ol;2-[2-(3,6-ditert-butylcarbazol-9-id-1-yl)-1-(3-phenylphenyl)benzimidazol-4-yl]-4-phenylquinolin-8-ol;platinum is sourced from PubChem (CID 158299713), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).